Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Torrent Pharmaceuticals Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 9 October 2026, 9:45 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price4,657₹ per share
Reported P/E78.4Times
Book value per share248₹ per share
Reported ROCE15.2 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Financial changes explained

Automatically calculated historical comparisons. Amounts are in ₹ crore unless stated otherwise. These summaries describe reported figures and do not rate or recommend the shares.

Reporting coverage: Quarterly: Jun 2026 · Annual: Mar 2026 · Cash flow: Mar 2026 · Balance sheet: Mar 2026.

Quarterly revenue change

Quarterly revenue was ₹4,921.00 crore in Jun 2026, compared with ₹3,178.00 crore in Jun 2025. The change was an increase of ₹1,743.00 crore. Year-on-year change: +54.8%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Quarterly net result change

Quarterly net result was ₹566.00 crore in Jun 2026, compared with ₹548.00 crore in Jun 2025. The change was an increase of ₹18.00 crore. Year-on-year change: +3.3%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Annual revenue change

Annual revenue was ₹13,980.00 crore in Mar 2026, compared with ₹11,516.00 crore in Mar 2025. The change was an increase of ₹2,464.00 crore. Year-on-year change: +21.4%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Annual net result change

Annual net result was ₹2,138.00 crore in Mar 2026, compared with ₹1,911.00 crore in Mar 2025. The change was an increase of ₹227.00 crore. Year-on-year change: +11.9%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Quarterly net profit margin

Calculated net profit margin moved from 17.24% in Jun 2025 to 11.50% in Jun 2026: 5.74 percentage points lower.

Calculation and source

Margin = net profit ÷ revenue × 100. Margin change is measured in percentage points; rounded source figures can affect the result.

Basis: consolidated. Period: 2025-06 to 2026-06.

View the financial table · Data source

Eight-quarter revenue comparison

Revenue across the four quarters ending Jun 2026 totalled ₹15,723.00 crore, compared with ₹11,835.00 crore across the preceding four quarters. The change was 32.9%.

Calculation and source

Sum four consecutive quarters and compare with the preceding four non-overlapping quarters. All eight observations must exist.

Basis: consolidated. Period: 2024-09 to 2026-06.

View the financial table · Data source

Profit and operating cash flow

For Mar 2026, operating cash flow was ₹3,023.00 crore and net profit was ₹2,138.00 crore. Operating cash flow ÷ net profit was 1.41 times.

Calculation and source

These are different accounting measures. The ratio, when shown, uses the same reporting period and accounting basis; it is not an earnings-quality rating.

Basis: consolidated. Period: 2026-03.

View the financial table · Data source

Net profit history

Net profit was positive in 5 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Operating cash flow history

Operating cash flow was positive in 5 of 5 available annual observations in the five-year window ending Mar 2026.

Calculation and source

Count observations greater than zero. Missing years are excluded from both counts. Zero is not counted as positive.

Basis: consolidated. Period: 2022-03 to 2026-03.

View the financial table · Data source

Reported borrowings change

Reported borrowings was ₹15,026.00 crore in Mar 2026, compared with ₹3,202.00 crore in Mar 2025. The change was an increase of ₹11,824.00 crore. Year-on-year change: +369.3%.

Calculation and source

Absolute change = later amount − earlier amount. Percentage change = (later ÷ earlier − 1) × 100.

Basis: consolidated. Period: 2025-03 to 2026-03.

View the financial table · Data source

Summary generated: 12 Oct 2026, 04:50 IST. Figures may be rounded, delayed or restated. Comparisons follow the source’s annual and quarterly classifications; changes in reporting duration or accounting policies can limit comparability. Check original filings. No cause for a change is inferred from arithmetic alone.

Stored market and accounting figures

Price record: 9 October 2026, 9:45 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap1,74,940 Cr.
Current Price4,657
High / Low5,250/3,480
Stock P/E78.4
Book Value248
Dividend Yield0.82 %
ROCE15.2 %
ROE27.4 %
Face Value5.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Torrent Pharmaceuticals Ltd 1,74,940 Cr. 4,657 5,250/3,48078.4 2480.82 %15.2 %27.4 % 5.00
Laurus Labs Ltd 1,09,924 Cr. 2,037 2,065/843126 97.30.10 %16.0 %15.2 % 2.00
Cipla Ltd 1,05,249 Cr. 1,301 1,673/1,16629.4 4261.00 %15.5 %11.6 % 2.00
Dr Reddys Laboratories Ltd 99,911 Cr. 1,197 1,415/1,08031.0 4540.67 %13.0 %11.2 % 1.00
Mankind Pharma Ltd 98,508 Cr. 2,380 2,642/1,91043.6 3970.04 %13.7 %13.8 % 1.00
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Torrent Pharmaceuticals Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 2,5912,6602,7322,7452,8592,8892,8092,9593,1783,3023,3034,1974,921
Expenses 1,8001,8351,8631,8621,9551,9501,8951,9952,1462,2192,2152,8413,257
Operating Profit 7918258698839049399149641,0321,0831,0881,3561,664
OPM % 31%31%32%32%32%32%33%33%32%33%33%32%34%
Other Income 3426553124-1633-42-37-40-23-83-33
Interest 10391808075645756564845236305
Depreciation 191201213203197198199201201204206508593
Profit before tax 531559631631656661691665738791814529733
Tax % 29%31%30%29%30%31%27%25%26%25%22%31%23%
Net Profit 378386443449457453503498548591635364566
EPS in Rs 11.1711.4113.0913.2713.5013.3814.8614.7116.1917.4618.7610.7616.72

Last Updated: September 29, 2026, 5:05 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:50 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 4,6366,6875,8165,9507,6737,9398,0058,5089,62010,72811,51613,98015,723
Expenses 3,6163,9544,4384,6015,6905,7695,5246,0776,7787,3607,7959,42110,532
Operating Profit 1,0202,7331,3771,3491,9832,1702,4802,4312,8423,3683,7214,5585,191
OPM % 22%41%24%23%26%27%31%29%30%31%32%33%33%
Other Income 28632223299-30012157-28845146-1-182-179
Interest 175184206308504451353255333354252385634
Depreciation 1912383074096186546586627078087951,1191,511
Profit before tax 9402,3431,0889315621,1871,5261,2261,8472,3522,6732,8722,867
Tax % 20%26%14%27%22%14%18%37%33%30%28%26%
Net Profit 7511,7339346784361,0251,2527771,2451,6561,9112,1382,156
EPS in Rs 22.1951.2227.5920.0412.8930.2836.9922.9736.7948.9456.4763.9263.70
Dividend Payout % 25%34%25%35%66%53%47%105%60%57%57%59%

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)130.76%-46.11%-27.41%-35.69%135.09%22.15%-37.94%60.23%33.01%15.40%11.88%
Change in YoY Net Profit Growth (%)0.00%-176.86%18.70%-8.28%170.78%-112.95%-60.09%98.17%-27.22%-17.61%-3.52%

Torrent Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2015-2016 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:10%
5 Years:8%
3 Years:11%
TTM:8%
Compounded Profit Growth
10 Years:10%
5 Years:14%
3 Years:21%
TTM:21%
Stock Price CAGR
10 Years:17%
5 Years:21%
3 Years:34%
1 Year:5%
Return on Equity
10 Years:23%
5 Years:23%
3 Years:24%
Last Year:27%

Last Updated: September 5, 2025, 1:46 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 24, 2026, 4:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 8585858585858585169169169169
Reserves 2,4063,4094,2664,5384,6404,7395,7535,8686,0296,6877,4218,219
Borrowings 2,7402,3522,5106,4626,0385,7844,8744,0705,3694,0223,20215,026
Other Liabilities 2,5893,0402,7403,1593,3513,4023,3632,8843,0433,6273,60320,200
Total Liabilities 7,8208,8869,60114,24314,11314,01014,07512,90614,61014,50514,39643,614
Fixed Assets 2,8332,8593,6887,8557,7487,5337,0656,4238,1218,1387,94733,191
CWIP 6781,042519647617712889630765361478641
Investments 2987808044923532181226199173156948
Other Assets 4,0114,2064,5895,2495,3955,7635,9405,6285,5245,8345,8158,833
Total Assets 7,8208,8869,60114,24314,11314,01014,07512,90614,61014,50514,39643,614
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 8102,7421,0098941,7981,3932,0051,8032,3683,2662,5853,023
Cash from Investing Activity + -2,113-869-798-4,677-246229-444-196-2,335-160-549-12,630
Cash from Financing Activity + 1,212-1,435-1933,417-1,314-1,549-1,651-1,78177-2,780-2,29810,151
Net Cash Flow -9043718-36623873-89-174110327-262544
Free Cash Flow 5742,1505231051,1389901,6711,6071,9532,9671,9912,386
CFO/OP 85%121%101%87%105%77%88%91%97%112%86%84%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow574.002,150.00523.00105.001,138.00990.001,671.001,607.001,953.002,967.001,991.002,386.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 9612579607768766970746359
Inventory Days 297275314318429318362456368298310334
Days Payable 421472523356447345345351250224284239
Cash Conversion Cycle -28-71-1302159429317418814789154
Working Capital Days 2429-128-80-62-52-57-33-277
ROCE %35%27%48%19%13%13%15%17%19%20%23%27%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Jul 2026
Promoters 71.25%71.25%71.25%71.25%68.31%68.31%68.31%68.31%68.31%68.31%68.31%60.78%
FIIs 14.08%14.14%14.22%14.46%16.17%16.31%16.09%15.92%16.13%16.18%15.44%17.97%
DIIs 7.11%7.15%7.17%6.98%8.25%8.25%8.54%9.17%9.05%8.96%9.73%12.77%
Government 0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.10%0.00%0.10%0.09%
Public 7.46%7.34%7.25%7.21%7.17%7.02%6.93%6.47%6.41%6.55%6.42%8.39%
No. of Shareholders 69,11771,15474,76579,84885,03586,00581,85678,22676,21483,81185,7761,40,599
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis Large Cap Fund 770,913 1.06 322.63964,7512026-06-11 03:46:23-20.09%
Axis Large & Mid Cap Fund 387,176 1.04 162.04N/AN/AN/A
Nippon India Value Fund 328,626 1.54 137.53353,6262025-11-03 03:03:49-7.07%
Kotak Large Cap Fund 323,926 1.28 135.57190,4702026-03-24 02:01:0570.07%
Axis ELSS Tax Saver Fund 279,714 0.37 117.06337,0922026-06-11 03:46:23-17.02%
Franklin India Large Cap Fund 241,893 1.4 101.23582,0222026-06-11 03:46:23-58.44%
NJ Balanced Advantage Fund 195,637 2.38 81.88N/AN/AN/A
Aditya Birla Sun Life Consumption Fund 185,000 1.29 77.42N/AN/AN/A
Tata Aggressive Hybrid Fund 176,100 1.91 73.7N/AN/AN/A
Aditya Birla Sun Life Value Fund 121,774 0.8 50.96N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 56.4748.9436.7945.9373.98
Diluted EPS (Rs.) 56.4748.9436.7945.9373.98
Cash EPS (Rs.) 79.9672.8257.6785.05112.84
Book Value[Excl.RevalReserv]/Share (Rs.) 224.27202.57183.13351.75344.90
Book Value[Incl.RevalReserv]/Share (Rs.) 224.27202.57183.13351.75344.90
Revenue From Operations / Share (Rs.) 340.25316.96284.23502.72472.97
PBDIT / Share (Rs.) 110.63101.2185.30155.27149.90
PBIT / Share (Rs.) 87.1477.3364.43116.15111.04
PBT / Share (Rs.) 78.9769.4954.5872.4490.18
Net Profit / Share (Rs.) 56.4748.9436.7945.9273.97
NP After MI And SOA / Share (Rs.) 56.4748.9436.7945.9273.97
PBDIT Margin (%) 32.5131.9330.0130.8831.69
PBIT Margin (%) 25.6124.3922.6623.1023.47
PBT Margin (%) 23.2021.9219.2014.4019.06
Net Profit Margin (%) 16.5915.4412.949.1315.63
NP After MI And SOA Margin (%) 16.5915.4412.949.1315.63
Return on Networth / Equity (%) 25.1724.1520.0913.0521.44
Return on Capital Employeed (%) 28.7127.1622.7922.6320.46
Return On Assets (%) 12.7510.998.295.938.89
Long Term Debt / Equity (X) 0.150.230.400.350.50
Total Debt / Equity (X) 0.390.570.850.670.82
Asset Turnover Ratio (%) 0.760.710.680.530.50
Current Ratio (X) 1.191.030.971.201.13
Quick Ratio (X) 0.650.610.560.640.58
Inventory Turnover Ratio (X) 4.780.730.630.680.69
Dividend Payout Ratio (NP) (%) 56.6661.2969.3087.0927.03
Dividend Payout Ratio (CP) (%) 40.0241.1944.2147.0217.72
Earning Retention Ratio (%) 43.3438.7130.7012.9172.97
Cash Earning Retention Ratio (%) 59.9858.8155.7952.9882.28
Interest Coverage Ratio (X) 14.849.698.6610.307.19
Interest Coverage Ratio (Post Tax) (X) 8.675.434.735.954.55
Enterprise Value (Cr.) 111924.9091136.9056758.9950939.2747229.23
EV / Net Operating Revenue (X) 9.728.505.905.995.90
EV / EBITDA (X) 29.8926.6019.6619.3818.62
MarketCap / Net Operating Revenue (X) 9.518.215.415.565.37
Retention Ratios (%) 43.3338.7030.6912.9072.96
Price / BV (X) 14.4212.848.397.957.37
Price / Net Operating Revenue (X) 9.518.215.415.565.37
EarningsYield 0.010.010.020.010.02
Advertisements
Explore Industry-wise Company financial data